It is an orally active multi-kinase inhibitor that acts as a cytotoxic chemotherapeutic, inhibiting tumor cell proliferation and inducing apoptotic cell death via inhibition of VEGF and PDGF receptors as well as the Raf/MEK/ERK pathway [60]. This evidence concerns the gene VEGFA and neoplasm.